Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
The idea that inhibiting tumour angiogenesis might be an effective anticancer strategy was proposed by Folkman over thirty years ago.
A number of molecules involved in angiogenesis have now been identified, including vascular endothelial growth factor (VEGF), which is an essential regulator of normal and pathological angiogenesis.<...
Alternative Titles
Full title
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_71917192
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71917192
Other Identifiers
ISSN
1474-1776
E-ISSN
1474-1784
DOI
10.1038/nrd1381
